|
Volumn 21, Issue 2, 2006, Pages 110-111
|
Economic evaluation of acute migraine attack treatment with triptans in Spain [1];Evaluatión económica del tratamiento de la crisis aguda de migraña con triptanes en España
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALMOTRIPTAN;
ANTIMIGRAINE AGENT;
SEROTONIN 1B AGONIST;
SEROTONIN 1D AGONIST;
SEROTONIN AGONIST;
TRYPTAMINE DERIVATIVE;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
HEADACHE;
HEALTH ECONOMICS;
HUMAN;
LETTER;
META ANALYSIS;
MIGRAINE;
NEUROTOXICITY;
SIDE EFFECT;
SPAIN;
SYSTEMATIC REVIEW;
CHEMISTRY;
ECONOMICS;
NOTE;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
HUMANS;
MIGRAINE DISORDERS;
SEROTONIN AGONISTS;
SPAIN;
TREATMENT OUTCOME;
TRYPTAMINES;
|
EID: 33645503936
PISSN: 02134853
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (7)
|